WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Software Products Friday, March 29, 2024 
Add Press Release News | News Feeds Feeds | Email This News Email


Synopsys Replenishes Repurchase Authorization up to $500 Million
Thursday, June 24, 2021

MOUNTAIN VIEW, Calif., June 17, 2021 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today announced that its Board of Directors has replenished its existing stock repurchase authorization up to $500 million.

"The replenishment of our repurchase authorization reinforces our ongoing commitment to generate sustainable, long-term shareholder value," said Trac Pham, chief financial officer of Synopsys. "We continue to execute well on our strategy to balance strategic investments to grow the business, expand margins and return capital to stockholders."

Synopsys' Board of Directors originally approved the stock repurchase program in 2002 and has periodically replenished the program as funds are spent. The program does not obligate Synopsys to acquire any particular amount of common stock, and the program may be suspended or terminated at any time by the chief financial officer or the Board of Directors at their sole discretion.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software(TM) partner for innovative companies developing the electronic products and software applications we rely on every day. As an S&P 500 company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and offers the industry's broadest portfolio of application security testing tools and services. Whether you're a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing more secure, high-quality code, Synopsys has the solutions needed to deliver innovative products. Learn more at www.synopsys.com.

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements related to the timing and extent of stock repurchases, if any, and our planned deployment of capital. Forward-looking statements are subject to both known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. These risks and uncertainties include, among others: fluctuations in the market price of Synopsys common stock and our use of cash for other purposes. Other risks and uncertainties that may apply are set forth in the Risk Factors section of Synopsys' most recently filed Quarterly Report on Form 10-Q. Synopsys assumes no obligation to update any forward-looking statement contained in this press release.

INVESTOR CONTACT:
Lisa L. Ewbank
Synopsys, Inc.
650-584-1901
Synopsys-ir@synopsys.com

EDITORIAL CONTACT:
Simone Souza
Synopsys, Inc.
650-584-6454
simone@synopsys.com

View original content:http://www.prnewswire.com/news-releases/synopsys-replenishes-repurchase-authorization-up-to-500-million-301314731.html

SOURCE Synopsys, Inc.



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Weekly Recap: 12 Press Releases You Might Have Missed | Mar 29, 2024
Nav Global IoT in Agriculture Industry Research 2023-2033: Established Players Dominate the Growing Market | Mar 29, 2024
Nav Sony Electronics Delivers Firmware Updates including C2PA Compliancy as a Next Step to Ensure Authenticity of Images | Mar 29, 2024
Nav Airties Launches Orbit: Continuous Test Automation Platform for Managed Wi-Fi Deployments | Mar 29, 2024
Nav As RentRedi Expands Reporting to All Three Major Credit Bureaus, Landlords See 13% Jump in On-time Rent Payments | Mar 29, 2024
Nav Slenergy Focuses on Service Network in Europe | Mar 29, 2024
Nav Global Diagnostics Distribution Deal Trends Report and Directory 2024: Company A-Z, Headline Value, Therapeutic Area, Technology Type | Mar 29, 2024
Nav 2024 Emerging Trends Revolutionizing the Mobility Industry: Dynamic Changes Driven by Innovative Startups | Mar 29, 2024
Nav Whole Genome and Exome Sequencing Market Analysis 2023-2024 and 2027 with Executive and Consultant Guides Featuring llumina, ION, Pacific Biosystems, Roche, SOLiD, Oxford Nanopore Among Others | Mar 29, 2024
Nav /C O R R E C T I O N -- SEMIFIVE/ | Mar 29, 2024
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News